AnPac Bio-Medical Science ^Company

Anpac Bio-Medical Science Company, Ltd., is led by award-winning and internationally respected biomedical and nanotechnology scientists, medical professionals, and engineering experts -- creating and launching break-through, leading-edge, early cancer screening, detection, and diagnostic technology. Known as Anpac's "Cancer Differentiation Analysis" (CDA) program, Anpac's innovative and proprietary CDA medical devices measure “Blood Biopsies” -- effectively and dramatically-improving cancer detection sensitivity, and specificity, without producing any side-effects in patients. As demonstrated and confirmed in over 22,000 cases to date, Anpac’s CDA diagnostics can detect and identify early signals of threatening cancer – and the type of cancer (location in the body) – often before the threat becomes or grows into tumors.